Covered recipient · General Payments record
DOUGLAS J JONES
Allopathic & Osteopathic Physicians Surgery
General Payments · PY2018–2024
$241,714.56
- Reported across 201 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $149,750.00 | 49 |
| Food and Beverage | $355.13 | 6 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| CSL Plasma Inc. | $149,750.00 | 49 |
| DAVOL INC. | $310.53 | 4 |
| Integra LifeSciences Corporation | $27.71 | 1 |
| Pacira Pharmaceuticals Incorporated | $16.89 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (55)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| CSL Plasma Inc. | $2,125.00 | 01/10/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1134600423 | CMS |
| CSL Plasma Inc. | $2,375.00 | 01/10/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1134600425 | CMS |
| CSL Plasma Inc. | $3,250.00 | 01/24/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1134600427 | CMS |
| CSL Plasma Inc. | $1,250.00 | 01/29/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1134600429 | CMS |
| CSL Plasma Inc. | $3,625.00 | 02/20/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1134600431 | CMS |
| CSL Plasma Inc. | $2,250.00 | 03/27/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1134600433 | CMS |
| CSL Plasma Inc. | $1,000.00 | 04/05/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1134600435 | CMS |
| CSL Plasma Inc. | $2,750.00 | 04/29/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1134600437 | CMS |
| CSL Plasma Inc. | $2,375.00 | 05/13/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1134600439 | CMS |
| CSL Plasma Inc. | $2,250.00 | 05/29/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1134600441 | CMS |
| CSL Plasma Inc. | $3,125.00 | 06/05/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1134600443 | CMS |
| CSL Plasma Inc. | $1,750.00 | 06/24/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1134600445 | CMS |
| CSL Plasma Inc. | $1,625.00 | 07/03/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1142131189 | CMS |
| CSL Plasma Inc. | $3,250.00 | 07/10/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1142131191 | CMS |
| CSL Plasma Inc. | $2,000.00 | 07/10/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1142131193 | CMS |
| CSL Plasma Inc. | $4,750.00 | 07/10/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1142131195 | CMS |
| CSL Plasma Inc. | $250.00 | 07/10/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1142131197 | CMS |
| CSL Plasma Inc. | $3,875.00 | 07/10/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1142131199 | CMS |
| CSL Plasma Inc. | $1,875.00 | 07/10/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1142131201 | CMS |
| CSL Plasma Inc. | $3,875.00 | 07/10/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1142131259 | CMS |
| CSL Plasma Inc. | $2,500.00 | 07/24/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1142131203 | CMS |
| CSL Plasma Inc. | $3,500.00 | 08/14/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1142131205 | CMS |
| CSL Plasma Inc. | $875.00 | 08/21/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1142131207 | CMS |
| CSL Plasma Inc. | $1,250.00 | 08/21/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1142131209 | CMS |
| CSL Plasma Inc. | $4,875.00 | 08/21/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1142131211 | CMS |
| CSL Plasma Inc. | $2,875.00 | 08/21/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1142131213 | CMS |
| CSL Plasma Inc. | $4,375.00 | 08/21/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1142131215 | CMS |
| CSL Plasma Inc. | $3,500.00 | 08/21/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1142131217 | CMS |
| CSL Plasma Inc. | $250.00 | 08/21/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1142131219 | CMS |
| CSL Plasma Inc. | $1,750.00 | 08/28/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1142131221 | CMS |
| CSL Plasma Inc. | $5,750.00 | 09/11/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1142131223 | CMS |
| CSL Plasma Inc. | $2,875.00 | 09/18/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1142131225 | CMS |
| CSL Plasma Inc. | $5,000.00 | 10/09/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1142131227 | CMS |
| CSL Plasma Inc. | $3,500.00 | 10/09/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1142131229 | CMS |
| CSL Plasma Inc. | $4,000.00 | 10/09/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1142131231 | CMS |
| CSL Plasma Inc. | $5,250.00 | 10/09/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1142131233 | CMS |
| CSL Plasma Inc. | $3,375.00 | 10/23/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1142131235 | CMS |
| CSL Plasma Inc. | $5,625.00 | 10/23/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1142131237 | CMS |
| CSL Plasma Inc. | $2,250.00 | 10/30/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1142131239 | CMS |
| CSL Plasma Inc. | $3,500.00 | 11/27/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1142131241 | CMS |
| CSL Plasma Inc. | $3,250.00 | 12/04/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1142131243 | CMS |
| CSL Plasma Inc. | $2,750.00 | 12/04/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1142131245 | CMS |
| CSL Plasma Inc. | $3,000.00 | 12/04/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1142131247 | CMS |
| CSL Plasma Inc. | $2,625.00 | 12/04/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1142131249 | CMS |
| CSL Plasma Inc. | $5,750.00 | 12/04/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1142131251 | CMS |
| CSL Plasma Inc. | $2,750.00 | 12/04/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1142131261 | CMS |
| CSL Plasma Inc. | $5,750.00 | 12/11/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1142131253 | CMS |
| CSL Plasma Inc. | $2,750.00 | 12/18/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1142131255 | CMS |
| CSL Plasma Inc. | $4,625.00 | 12/18/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1142131257 | CMS |
| Davol Inc. | $127.00 | 01/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1127658935 | CMS |
| Davol Inc. | $36.45 | 04/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1127658943 | CMS |
| Davol Inc. | $64.25 | 09/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1127658949 | CMS |
| Davol Inc. | $82.83 | 10/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1127658955 | CMS |
| Integra LifeSciences Corporation | $27.71 | 02/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1140092401 | CMS |
| Pacira Pharmaceuticals Incorporated | $16.89 | 10/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151244210 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.